Martina Bortolami

Dr. Martina Bortolami

Department of Scienze di Base e Applicate per l’Ingegneria (SBAI), Sapienza University of Rome, via del Castro Laurenziano, 7, 00161 Roma, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in ChemElectroChem
Verified
Journal Article
Open access
DRDaniele Rocco
Daniele Rocco
VMVyali Georgian Moldoveanu
Vyali Georgian Moldoveanu
Marta FerociMarta Feroci
Marta Feroci
Martina BortolamiMartina Bortolami
Martina Bortolami
FVFabrizio Vetica
Fabrizio Vetica
Carbon quantum dots (CDs) are “small” carbon nanostructures with excellent photoluminescence properties, together with low‐toxicity, high biocompatibility, excellent dispersibility in water as well as organic solvents. Due to their characteristics, CDs have been studied for a plethora of applications as biosensors, luminescent probes for photodynamic and photothermal therapy, fluorescent inks and many more. Moreover, the possibility to obtain carbon dots from biomasses and/or organic waste has strongly promoted the interest in this class of carbon‐based nanoparticles, having a promising impact in the view of circular economy and sustainable processes. Within this context, electrochemistry proved to be a green, practical, and efficient method for the synthesis of high‐quality CDs, with the possibility to fine‐tune their characteristics by changing operational parameters. This review outlines the principal and most recent advances in the electrochemical synthesis of CDs, focusing on the electrochemical set‐up optimization.

14 March 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Rita PetrucciRita Petrucci
Rita Petrucci
Martina BortolamiMartina Bortolami
Martina Bortolami
paola di matteopaola di matteo
paola di matteo
Antonella CurulliAntonella Curulli
Antonella Curulli
Antioxidants play a central role in the development and production of food, cosmetics, and pharmaceuticals, to reduce oxidative processes in the human body. Among them, phenolic antioxidants are considered even more efficient than other antioxidants. They are divided into natural and synthetic. The natural antioxidants are generally found in plants and their synthetic counterparts are generally added as preventing agents of lipid oxidation during the processing and storage of fats, oils, and lipid-containing foods: All of them can exhibit different effects on human health, which are not always beneficial. Because of their relevant bioactivity and importance in several sectors, such as agro-food, pharmaceutical, and cosmetic, it is crucial to have fast and reliable analysis Rmethods available. In this review, different examples of gold nanomaterial-based electrochemical (bio)sensors used for the rapid and selective detection of phenolic compounds are analyzed and discussed, evidencing the important role of gold nanomaterials, and including systems with or without specific recognition elements, such as biomolecules, enzymes, etc. Moreover, a selection of gold nanomaterials involved in the designing of this kind of (bio)sensor is reported and critically analyzed. Finally, advantages, limitations, and potentialities for practical applications of gold nanomaterial-based electrochemical (bio)sensors for detecting phenolic antioxidants are discussed.

14 January 2021 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
Martina BortolamiMartina Bortolami
Martina Bortolami
DRDaniele Rocco
Daniele Rocco
AMAntonella Messore
Antonella Messore
RSRoberto Di Santo
Roberto Di Santo
Roberta CostiRoberta Costi
Roberta Costi
Fabiana PandolfiFabiana Pandolfi
Fabiana Pandolfi
Introduction – AD, the most common form of dementia, has a multifactorial etiology, and the current therapy (AChEIs and memantine) is unable to interrupt its progress and fatal outcome. This is reflected in the research programs that are oriented toward the development of new therapeutics able to operate on multiple targets involved in the disease progression. Areas covered – The patents from 2016 to present regarding the use of AChEIs in AD, concerns the development of new AChEIs, multitarget or multifunctional ligands, or the associations of currently used AChEIs with other compounds acting on different targets involved in the AD. Expert opinion – The development of new multitarget AChEIs promises to identify compounds with great therapeutic potential but requires more time and effort in order to obtain drugs with the optimal pharmacodynamic profile. Otherwise, the research on new combinations of existing drugs, with known pharmacodynamic and ADME profile, could shorten the time and reduce the costs to develop a new therapeutic treatment for AD. From the analyzed data, it seems more likely that a response to the urgent need to develop effective treatments for AD therapy could come more quickly from studies on drug combinations than from the development of new AChEIs.

1 December 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FPFabiana Pandolfi
Fabiana Pandolfi
Daniela De VitaDaniela De Vita
Daniela De Vita
Martina BortolamiMartina Bortolami
Martina Bortolami
ACAntonio Coluccia
Antonio Coluccia
RSRoberto Di Santo
Roberto Di Santo
Luigi ScipioneLuigi Scipione
Luigi Scipione

1 July 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Martina BortolamiMartina Bortolami
Martina Bortolami
FPFabiana Pandolfi
Fabiana Pandolfi
Daniela De VitaDaniela De Vita
Daniela De Vita
CCCamilla Carafa
Camilla Carafa
AMAntonella Messore
Antonella Messore
Luigi ScipioneLuigi Scipione
Luigi Scipione

12 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Martina BortolamiMartina Bortolami
Martina Bortolami
IBIngrid Izabela Bogles
Ingrid Izabela Bogles
Cecilia BombelliCecilia Bombelli
Cecilia Bombelli
Fabiana PandolfiFabiana Pandolfi
Fabiana Pandolfi
Marta FerociMarta Feroci
Marta Feroci
FVFabrizio Vetica
Fabrizio Vetica
Chirality is undoubtedly a fundamental property of nature since the different interactions of optically active molecules in a chiral environment are essential for numerous applications. Thus, in the field of asymmetric synthesis, the search for efficient, sustainable, cost-effective and recyclable chiral catalysts is still the main challenge in organic chemistry. The field of carbon dots (CDs) has experienced tremendous development in the last 15 years, including their applications as achiral catalysts. Thus, understanding the implications of chirality in CDs chemistry could be of utmost importance to achieving sustainable and biocompatible chiral nanocatalysts. An efficient and cost-effective electrochemical synthetic methodology for the synthesis of L-Proline-based chiral carbon dots (CCDs) and EtOH-derived L-Proline-based chiral carbon dots (CCDs) is herein reported. The electrochemical set-up and reaction conditions have been thoroughly optimised and their effects on CCDs size, photoluminescence, as well as catalytic activity have been investigated. The obtained CCDs have been successfully employed to catalyze an asymmetric aldol reaction, showing excellent results in terms of yield, diastereo- and enantioselectivity. Moreover, the sustainable nature of the CCDs was demonstrated by recycling the catalysts for up to 3 cycles without any loss of reactivity or stereoselectivity.